# Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury

> **NCT04194671** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Acute Kidney Injury
- Mesenchymal Stem Cells

## Interventions

- **BIOLOGICAL:** Mesenchymal stem cells
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT04194671
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-31
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04194671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04194671, "Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04194671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*